Isabelle Desombere

Head of Laboratory Immune Response; Responsible NRC Bordetella pertussis and NRC toxigenic Corynebacteria (consortium with UZBrussel)

Sciensano (Belgium)

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Isabelle Desombere is the Head of Laboratory Immune Response at Sciensano in Belgium. Her research primarily focuses on immune responses related to COVID-19, particularly in high-risk populations such as hemodialysis and lung transplant recipients. Recent publications include studies on the effects of COVID-19 vaccine responses and seroprevalence in various demographics within Belgium.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Andre Matagne

Professor

University of Liege

BELGIUM

View details

Joanna Merckx

Assistant Professor

McGill University

CANADA

View details

Jan Verbakel

University of Oxford

UNITED KINGDOM

View details

Robin Bruyndonckx

Senior statistician - Head of Statistics as of September 2023

BELGIUM

View details

An De Sutter

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Isabelle Desombere

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients

COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients.

Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.

Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial.

Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022.

Validation of a rapid SARS-CoV-2 antibody test in general practice

SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.

Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults

Combined deficient response to polysaccharide-based and protein-based vaccines predicts a severe clinical phenotype.

SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.

Collaborators (5)

Andre Matagne

Joanna Merckx

Jan Verbakel

Robin Bruyndonckx

An De Sutter

Make your next move.